Guenter R. Janhofer
Nessuna posizione attualmente
Profilo
Guenter R.
Janhofer worked as a Medical Director at Desitin Arzneimittel GmbH and as Vice President-Global Medical & Scientific Affairs at Merck & Co., Inc. He also served as Chief Medical Officer & Head-Development at BTG Ltd.
from 2012 to 2015 and as Head of Development at BTG International, Inc. Dr. Janhofer holds a doctorate degree from Ruhr-Universität Bochum, the University of Hamburg, and the Technical University of Berlin.
Precedenti posizioni note di Guenter R. Janhofer
| Società | Posizione | Fine |
|---|---|---|
Desitin Arzneimittel GmbH
 Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Chief Tech/Sci/R&D Officer | - |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | - |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Corporate Officer/Principal | - |
| BTG | Chief Tech/Sci/R&D Officer | - |
Formazione di Guenter R. Janhofer
| Ruhr-Universität Bochum | Doctorate Degree |
| University of Hamburg | Doctorate Degree |
| Technical University of Berlin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 3 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Finance |
Desitin Arzneimittel GmbH
Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Health Technology |
- Borsa valori
- Insiders
- Guenter R. Janhofer
